Nutex Health Inc. (NASDAQ:NUTX) Receives Average Recommendation of “Moderate Buy” from Brokerages

Nutex Health Inc. (NASDAQ:NUTX) has received a consensus recommendation of “Moderate Buy” from the five ratings firms that are covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $243.3333.

A number of research analysts have commented on the stock. Wall Street Zen upgraded shares of Nutex Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Zacks Research upgraded shares of Nutex Health to a “hold” rating in a research note on Monday. Lake Street Capital assumed coverage on shares of Nutex Health in a research note on Tuesday, June 2nd. They set a “buy” rating and a $235.00 price objective on the stock. Weiss Ratings upgraded shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday, May 4th. Finally, B. Riley Financial assumed coverage on shares of Nutex Health in a research note on Friday, June 26th. They set a “buy” rating and a $290.00 price objective on the stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Bank of America Corp DE lifted its position in shares of Nutex Health by 52.3% in the 1st quarter. Bank of America Corp DE now owns 9,027 shares of the company’s stock worth $858,000 after buying an additional 3,101 shares during the last quarter. Smith Group Asset Management LLC bought a new position in shares of Nutex Health in the 1st quarter worth about $1,244,000. EverSource Wealth Advisors LLC bought a new position in shares of Nutex Health in the 1st quarter worth about $83,000. Empowered Funds LLC bought a new position in shares of Nutex Health in the 1st quarter worth about $3,084,000. Finally, Quantinno Capital Management LP bought a new position in shares of Nutex Health in the 1st quarter worth about $843,000. 5.32% of the stock is currently owned by institutional investors.

Nutex Health Stock Performance

Nutex Health stock opened at $170.89 on Wednesday. Nutex Health has a 12-month low of $77.21 and a 12-month high of $193.07. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.14 and a quick ratio of 3.12. The company has a market capitalization of $1.18 billion, a price-to-earnings ratio of 13.21 and a beta of 0.26. The firm’s fifty day moving average price is $131.86 and its 200 day moving average price is $129.94.

Nutex Health (NASDAQ:NUTX) last posted its quarterly earnings data on Thursday, April 30th. The company reported $6.52 EPS for the quarter, beating analysts’ consensus estimates of $3.99 by $2.53. Nutex Health had a net margin of 10.95% and a return on equity of 23.50%. The firm had revenue of $216.49 million for the quarter, compared to the consensus estimate of $227.80 million. On average, research analysts forecast that Nutex Health will post 22.72 EPS for the current fiscal year.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.